treatment form (oral or intramuscular hydroxocobalamin) depends on the underlying cause
The following may increase your risk of developing a vit B12 deficiency: High alcohol Gastritis Celiac disease Older age Crohns Vegan/Vegetarian diet Pernicious anaemia GI Surgery Pancreatic insufficiency pylori infection A full medical consultation and assessment will be carried out and referrals to other health professionals may sometimes be necessary prior to treatment

may cause iron-deficiency anemia Nausea and vomiting particularly with stricturing disease/obstruction Urgency and tenesmus with rectal/colonic involvement Weight loss and malnutrition due to malabsorption, food avoidance, elevated metabolic demand Fever with active inflammation, abscess, or fistula Perianal disease fissures, fistulae, skin tags, abscesses Extraintestinal Manifestations Arthropathy peripheral or axial (enteropathic arthritis, M07.6x) Dermatologic: Erythema nodosum (L52), pyoderma gangrenosum, psoriasis (L40.5) Ocular: Uveitis/iritis (H20.01), episcleritis, scleritis Hepatobiliary: Primary sclerosing cholangitis (K73.2), fatty liver, cholelithiasis Metabolic: Osteopenia/osteoporosis (from steroid use and malabsorption), nephrolithiasis Hematologic: Anemia (iron deficiency, B12/folate deficiency, anemia of chronic disease) When a patient with Crohns disease is admitted with significant weight loss, malnutrition, or protein-calorie deficiency , query the provider to specify the degree of malnutrition (mild, moderate, severe protein-calorie malnutrition)

Research and Development BPC-157 was originally developed over 20 years ago as an anti-ulcer agent due to its marked cytoprotective benefits
Thromboembolism in pregnancy